SICI-GISE Position Document on the Use of the Magmaris Resorbable Magnesium Scaffold in Clinical Practice-Reference-Cited by-同舟云学术

SICI-GISE Position Document on the Use of the Magmaris Resorbable Magnesium Scaffold in Clinical Practice

Published:2022-01 Issue: Volume:34 Page:11-16
ISSN:1553-8389
Container-title:Cardiovascular Revascularization Medicine
language:en
Short-container-title:Cardiovascular Revascularization Medicine

Author:

Galli Stefano,Testa Luca,Montorsi Piero,Bedogni Francesco,Pisano Francesco,Palloshi Altin,Mauro Ciro,Contarini Marco,Varbella Ferdinando,Esposito Giovanni,Caramanno Giovanni,Secco Gioel Gabrio,D'Amico Gianpiero,Musumeci Giuseppe,Tarantini Giuseppe

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference30 articles.

1. Bioresorbable scaffolds: rationale, current status, challenges, and future;Iqbal;Eur Heart J,2014

2. Coronary bioresorbable vascular scaffold use in the treatment of coronary artery disease;Testa;Circ Cardiovasc Interv,2016

3. Bioresorbable scaffolds: a new paradigm in percutaneous coronary intervention;Tenekecioglu;BMC Cardiovasc Disord,2016

4. Magmaris preliminary recommendation upon commercial launch: a consensus from the expert panel on 14 April 2016;Fajadet;EuroIntervention,2016

5. 2018 ESC/EACTS guidelines on myocardial revascularization;Neumann;Eur Heart J,2019

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of acute versus stable coronary syndrome in patients treated with the Magmaris scaffold: Two-year results from the Magmaris Multicenter Italian Registry;Cardiovascular Revascularization Medicine;2023-12

2. Research on the Current Application Status of Magnesium Metal Stents in Human Luminal Cavities;Journal of Functional Biomaterials;2023-09-08

3. A new resorbable magnesium scaffold for de novo coronary lesions (DREAMS 3): one-year results of the BIOMAG-I first-in-human study;EuroIntervention;2023-08

4. Final 36-Month Outcomes from the Multicenter DynamX Study Evaluating a Novel Thin-Strut Novolimus-Eluting Coronary Bioadaptor System and Supporting Preclinical Data;Reviews in Cardiovascular Medicine;2023-08-01

5. Safety and performance of the third-generation drug-eluting resorbable coronary magnesium scaffold system in the treatment of subjects with de novo coronary artery lesions: 6-month results of the prospective, multicenter BIOMAG-I first-in-human study;eClinicalMedicine;2023-05